Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325–331

Detalles Bibliográficos
Autores principales: Abdul-Ghani, Muhammad, Migahid, Osama, Megahed, Ayman, Adams, John, Triplitt, Curtis, DeFronzo, Ralph A., Zirie, Mahmoud, Jayyousi, Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521968/
https://www.ncbi.nlm.nih.gov/pubmed/28615237
http://dx.doi.org/10.2337/dc17-er08d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521968/
https://www.ncbi.nlm.nih.gov/pubmed/28615237
http://dx.doi.org/10.2337/dc17-er08d

Ejemplares similares